Traumatic Arthritis
54
6
19
16
Key Insights
Highlights
Success Rate
62% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 59/100
18.5%
10 terminated out of 54 trials
61.5%
-25.0% vs benchmark
6%
3 trials in Phase 3/4
56%
9 of 16 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 16 completed trials
Clinical Trials (54)
Perform® Humeral System - Fracture Study (PFX)
EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN))
The Post-marketing Surveillance to Evaluate the Efficacy and Safety of a CHONDRON (Autologous Cultured Chondrocyte)
The Post-marketing Surveillance to Evaluate the Efficacy of CHONDRON (Autologous Cultured Chondrocyte) by Arthroscopy
Tornier HRS (Humeral Reconstruction System) Study (REVIVE)
Persona Total Knee Arthroplasty Outcomes Study
Pyrocarbon Clinical Follow-up Study
Persona OsseoTi Keel Compatibility Study (Total Knee Arthroplasty)
Cemented vs Cementless Persona Keel RCT
Randomized Controlled Clinical Evaluation to Compare Vanguard Cruciate Retaining and AGC Total Condylar Knee Implants
Zimmer POLAR Persona - TKA (EMEA Study)
A Prospective, Clinical Investigation of the Vanguard 360 Revision Knee
Persona Ti-Nidium Post-Market Clinical Follow-up
Prospective Study for the Evaluation of the Cementless Anatomic Femoral Stem Minimax -Launay
The Medacta Quadra-P Anteverted Study
The Medacta International SMS Post-Marketing Surveillance Study
The Medacta International GMK Sphere Cementless Post-Marketing Surveillance Study
Post Market Clinical Follow-Up KeriFlex®
Long Term Follow-up of Integra® Cadence™ Total Ankle System in Primary Ankle Joint Replacement
Actis Total Hip System 2 Year Follow-up